BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 16791447)

  • 1. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
    Fagotti A; Ferrandina G; Fanfani F; Ercoli A; Lorusso D; Rossi M; Scambia G
    Ann Surg Oncol; 2006 Aug; 13(8):1156-61. PubMed ID: 16791447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score.
    Brun JL; Rouzier R; Uzan S; Daraï E
    Gynecol Oncol; 2008 Sep; 110(3):354-9. PubMed ID: 18572226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
    Fagotti A; Ferrandina G; Fanfani F; Garganese G; Vizzielli G; Carone V; Salerno MG; Scambia G
    Am J Obstet Gynecol; 2008 Dec; 199(6):642.e1-6. PubMed ID: 18801470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
    Chi DS; Venkatraman ES; Masson V; Hoskins WJ
    Gynecol Oncol; 2000 May; 77(2):227-31. PubMed ID: 10785469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
    Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
    Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
    Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer.
    Fagotti A; Vizzielli G; Costantini B; Lecca A; Gallotta V; Gagliardi ML; Scambia G; Fanfani F
    Acta Obstet Gynecol Scand; 2011 Oct; 90(10):1126-31. PubMed ID: 21707553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
    Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A
    Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing interval debulking surgery.
    Chereau E; Lavoue V; Ballester M; Coutant C; Selle F; Cortez A; Daraï E; Leveque J; Rouzier R
    Anticancer Res; 2011 Dec; 31(12):4469-74. PubMed ID: 22199317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer.
    Gemer O; Segal S; Kopmar A
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):583-5. PubMed ID: 11380298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
    Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
    Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second look for ovarian cancer: laparoscopy or Laparotomy? A prospective comparative study.
    Clough KB; Ladonne JM; Nos C; Renolleau C; Validire P; Durand JC
    Gynecol Oncol; 1999 Mar; 72(3):411-7. PubMed ID: 10053115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies.
    Varnoux C; Huchon C; Bats AS; Bensaid C; Achouri A; Nos C; Lécuru F
    Eur J Surg Oncol; 2013 Jul; 39(7):774-9. PubMed ID: 23597496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma.
    de Jong D; Eijkemans MJ; Lie Fong S; Gerestein CG; Kooi GS; Baalbergen A; van der Burg ME; Burger CW; Ansink AC
    Oncology; 2007; 72(5-6):293-301. PubMed ID: 18198490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study.
    Fagotti A; Fanfani F; Ludovisi M; Lo Voi R; Bifulco G; Testa AC; Scambia G
    Gynecol Oncol; 2005 Mar; 96(3):729-35. PubMed ID: 15721418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: A prospective validation study.
    Tomar TS; Nair RP; Sambasivan S; Krishna KMJ; Mathew A; Ahmed IM
    Indian J Cancer; 2017; 54(3):550-555. PubMed ID: 29798957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of computed tomography in the staging and predicting resectability of primary advanced ovarian carcinoma].
    Lou FL; Shi YF
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):701-5. PubMed ID: 17274380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
    Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G
    Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer.
    Gemer O; Lurian M; Gdalevich M; Kapustian V; Piura E; Schneider D; Lavie O; Levy T; Fishman A; Dgani R; Levavi H; Beller U
    Eur J Surg Oncol; 2005 Nov; 31(9):1006-10. PubMed ID: 16005601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advanced ovarian cancer: criteria of resectability].
    Chéreau E; Ballester M; Rouzier R; Coutant C; Daraï E
    Bull Cancer; 2009 Dec; 96(12):1189-97. PubMed ID: 19919915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.